Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis

Thomas A. Pollak*, Matthew J. Kempton, Conrad Iyegbe, Angela Vincent, Sarosh R. Irani, Ester Coutinho, David A. Menassa, Leslie Jacobson, Lieuwe de Haan, Stephan Ruhrmann, Gabriele Sachs, Anita Riecher-Roessler, Marie-Odile Krebs, Paul Amminger, Birte Glenthoj, Neus Barrantes-Vidal, Jim van Os, Bart P. F. Rutten, Rodrigo A. Bressan, Mark van der GaagRobert Yolken, Matthew Hotopf, Lucia Valmaggia, James Stone, Anthony S. David, Philip McGuire, Maria Calem, Stefania Tognin, Gemma Modinos, Eva Velthorst, Tamar C. Kraan, Daniella S. van Dam, Nadine Burger, Barnaby Nelson, Patrick McGorry, Christos Pantelis, Athena Politis, Joanne Goodall, Stefan Borgwardt, Sarah Ittig, Erich Studerus, Renata Smieskova, Philippe A. Delespaul, EUGEI High-Risk Study Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2590-2604
Number of pages15
JournalMolecular Psychiatry
Volume26
Issue number6
Early online date19 Oct 2020
DOIs
Publication statusPublished - Jun 2021

Keywords

  • ASPARTATE RECEPTOR AUTOANTIBODIES
  • 1ST-EPISODE PSYCHOSIS
  • NEURONAL AUTOANTIBODIES
  • LIMBIC ENCEPHALITIS
  • RATING-SCALE
  • MENTAL STATE
  • HIPPOCAMPAL
  • ANTIBODIES
  • BRAIN
  • INDIVIDUALS

Cite this